FIELD: medicine; ophthalmology.
SUBSTANCE: drug therapy is carried out with the help of emoxipine 1% — 1.0, intramuscularly, ethylmethylhydroxypyridine succinate 2.0 intramuscularly, with alternating thiamine 5% and pyridoxine 5% — 1.0 intramuscularly daily for 10 days. Additionally, a course of training with hypercapnic hypoxia is carried out with the help of Carbonic breathing device according to the following scheme: daily, for 20 minutes, the course is 10 days.
EFFECT: method makes it possible to increase the effectiveness of preventing the progression of primary open-angle glaucoma, improve the outflow of intraocular fluid and reduce the Becker coefficient in patients in the advanced stage of the disease.
1 cl, 1 dwg, 2 ex
Authors
Dates
2023-05-29—Published
2022-06-21—Filed